These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7804735)

  • 1. Mechanisms, markers and management of coagulation activation.
    Mannucci PM
    Br Med Bull; 1994 Oct; 50(4):851-70. PubMed ID: 7804735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the prethrombotic state due to procoagulant imbalance.
    Mannucci PM; Giangrande PL
    Eur J Haematol; 1992 Feb; 48(2):65-9. PubMed ID: 1547877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation markers of coagulation.
    Bauer KA
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):387-406. PubMed ID: 10856977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of activated coagulation and their usefulness in the clinical laboratory.
    Tripodi A; Mannucci PM
    Clin Chem; 1996 May; 42(5):664-9. PubMed ID: 8653889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.
    Wheeler AP; Gailani D
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1099-114. PubMed ID: 27637310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
    Mani H; Hesse C; Stratmann G; Lindhoff-Last E
    Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of continuous venovenous hemofiltration on coagulation activation.
    Bouman CS; de Pont AC; Meijers JC; Bakhtiari K; Roem D; Zeerleder S; Wolbink G; Korevaar JC; Levi M; de Jonge E
    Crit Care; 2006; 10(5):R150. PubMed ID: 17069648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetic model and simulation of blood coagulation--the kinetic influence of activated protein C.
    Qiao YH; Xu CQ; Zeng YJ; Xu XH; Zhao H; Xu H
    Med Eng Phys; 2004 May; 26(4):341-7. PubMed ID: 15121060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation cascade.
    Green D
    Hemodial Int; 2006 Oct; 10 Suppl 2():S2-4. PubMed ID: 17022746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms, markers and management of hypercoagulable states.
    Mannuci PM; Tripodi A
    Haemostasis; 1996 Oct; 26 Suppl 4():1-8. PubMed ID: 8979106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study.
    Duchow J; Ames M; Hess T; Seyfert U
    J Arthroplasty; 2001 Oct; 16(7):844-9. PubMed ID: 11607899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haemostaseological aspects of perioperative blood management].
    Scherer RU
    Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors.
    Stenflo J
    Crit Rev Eukaryot Gene Expr; 1999; 9(1):59-88. PubMed ID: 10200912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.
    Rapaport SI
    West J Med; 1993 Feb; 158(2):153-61. PubMed ID: 8434467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.
    Kannemeier C; Shibamiya A; Nakazawa F; Trusheim H; Ruppert C; Markart P; Song Y; Tzima E; Kennerknecht E; Niepmann M; von Bruehl ML; Sedding D; Massberg S; Günther A; Engelmann B; Preissner KT
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6388-93. PubMed ID: 17405864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.